Skip to main content

Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies

  • Book
  • © 2021

Overview

  • Offers a comprehensive analysis of EDCs from their occurrence to induced metabolic disorders in humans
  • Provides detailed information to researchers and clinicians investigating metabolic disorders
  • Discusses treatment strategies and regulatory considerations of EDCs-induced metabolic disorders

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (29 chapters)

  1. Introduction to Endocrine System and Metabolic Disorders

  2. Role of Endocrine Disrupting Chemicals in Metabolic Disorders

Keywords

About this book

This volume offers a detailed and comprehensive analysis of Endocrine Disrupting Chemicals (EDCs), covering their occurrence, exposure to humans and the mechanisms that lead to the parthogenesis of EDCs-induced metabolic disorders. The book is divided into three parts. Part I describes the physiology of the human endocrine system, with special emphasis on various types of metabolic disorders along with risk factors that are responsible for the development of these disorders. Part II addresses all aspects of EDCs, including their role in the induction of various risk factors that are responsible for the development of metabolic disorders. Part III covers up-to-date environmental regulatory considerations and treatment strategies that have been adopted to cure and prevent EDCs-induced metabolic disorders. This section will primarily appeal to clinicians investigating the causes and treatment of metabolic disorders. The text will also be of interest to students and researchers in the fields of Environmental Pharmacology and Toxicology, Environmental Pollution, Pharmaceutical Biochemistry, Biotechnology, and Drug Metabolism/Pharmacokinetics.

Editors and Affiliations

  • Department of Pharmaceutical Chemistry, Government College University Faisalabad, Faisalabad, Pakistan

    Muhammad Sajid Hamid Akash

  • Department of Pharmacy, University of Agriculture Faisalabad, Faisalabad, Pakistan

    Kanwal Rehman

  • Department of Chemistry, COMSATS University Islamabad, Islamabad, Pakistan

    Muhammad Zaffar Hashmi

About the editors

Dr. Muhammad Sajid Hamid Akash (PAS Gold Medal) is an Associate Professor and Chair of the Department of Pharmaceutical Chemistry at Government College University, Faisalabad, Pakistan. Dr. Akash works on the impact of EDCs on various molecular and metabolic pathways that are involved in metabolic disorders, as well as their treatment strategies for EDC-induced metabolic disorders.

Dr. Kanwal Rehman is an Assistant Professor in the Department of Pharmacy, at the University of Agriculture, Faisalabad, Pakistan. Dr. Rehman is working on health issues related to metabolic syndrome. 

Dr. Muhammad Zaffar Hashmi is an Assistant Professor of Environmental Engineering in the Department of Chemistry at COMSATS University Islamabad Campus, Pakistan. Dr. Hashmi works on multiple water, soil, air and health related issues, and has expertise in developing environmentally sustainable and feasible technologies.


Bibliographic Information

Publish with us